Company: JUNS
Filing Date: 2025-10-17
Form Type: PRE 14A
Source: 0001493152-25-018523
Chunk: 26

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-10-17
Form: PRE 14A
Chunk 26
---
 determining each director’s status as an “independent director” under Rule 5605(a)(2) of the Nasdaq Marketplace Rules. Based upon such definition and SEC regulations, the Board has affirmatively determined that currently three of its seven directors (Christer Rosén, Marshall Hayward, Ph.D., and Alison D. Silva) are non-independent directors of the Company and four of its seven directors (Nicholas H. Hemmerly, Julie Kampf, Allison W. Brady, and Holger Weis) are “independent” directors under Nasdaq listing standards. Therefore, the Board has determined that a majority of the members of our Board are “independent”.

Committees of the Board of Directors

Audit Committee

We have established an audit committee (“ Audit Committee”), which consists of three independent directors: Holger Weis, Allison W. Brady and Nicholas Hemmerly. Mr. Weis is the chair of the Audit Committee. Mr. Weis qualifies as an audit committee financial expert under SEC rules and as a financially sophisticated audit committee member under the Nasdaq Capital Market rules. Our Audit Committee operates under a written charter that is reviewed annually. A copy of the charter is posted on the Corporate Governance section of our website, at www.jupiterneurosciences.com.

Our Audit Committee is authorized to:

| ● | approve                                                                                                 
 and retain the independent auditors to conduct the annual audit of our financial statements;            |
| ● | review                                                                                                  
 the proposed scope and results of the audit;                                                            |
| ● | review                                                                                                  
 and pre-approve audit and non-audit fees and services;                                                  |
| ● | review                                                                                                  
 accounting and financial controls with the independent auditors and our financial and accounting staff; |
| ● | review                                                                                                  
 and approve transactions between us and our directors, officers and affiliates;                         |
| ● | recognize                                                                                               
 and prevent prohibited non-audit services;                                                              |
| ● | establish                                                                                               
 procedures for complaints received by us regarding accounting matters; and                              |
| ● | oversee                                                                                                 
 internal audit functions, if any.                                                                       |

| -15- |

Compensation Committee

We have established a compensation committee (“ Compensation Committee”), which consists of three independent directors: Nicholas H. Hemmerly, Julie Kampf and Allison Brady. Mr. Hemmerly is the chair of the Compensation Committee. Our Compensation Committee operates under a written charter that is reviewed annually. A copy of the charter is posted on the Corporate Governance section of our website, at www